Resmed (RMD) announced the publication of a meta-analysis in The Lancet Respiratory Medicine, demonstrating that CPAP therapy significantly reduces the risk of death for people with obstructive ...

Its core business includes the development of devices for sleep apnea -- such as CPAP and APAP machines -- and digital health solutions. Key success factors for ResMed ... year bump up in earnings ...

In the second quarter of fiscal 2025, the company launched its breakthrough CPAP ... ResMed’s Brightree ReSupply and Snap technologyhas supported ResMed’s U.S. market growth, with Snap set ...